MOH — authorised 2 August 1990
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇮🇱 L-Dipalmitoyl Lecithin in Israel
MOH authorised L-Dipalmitoyl Lecithin on 2 August 1990
Marketing authorisation
L-Dipalmitoyl Lecithin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Israel
Frequently asked questions
Is L-Dipalmitoyl Lecithin approved in Israel?
Yes. MOH authorised it on 2 August 1990.
Who is the marketing authorisation holder for L-Dipalmitoyl Lecithin in Israel?
GLAXOSMITHKLINE holds the Israeli marketing authorisation.